Info |
---|
title | Instructions on how to use this template |
---|
| Copy ADQRS QS Template pages to the Initial development (Not ready for internal review). Please DO NOT OVERWRITE the template pages.Change the title of the page as follows:Remove 'Copy of ADQRS QS Template - '. The new title should begin with 'ADaM ADQRS Short_Name...'.Change 'ADQRS Short_Name' to the short name (QSCAT) for the current measure.- This change needs to be done in the title as well as throughout the document.
The version number will be 'v1' if there has never been a supplement for the measure before. Otherwise, increment as appropriate.When copyrighted instruments are used, 'Public domain' will need to be changed to 'Approved'. Note that the copyright approval must allow for the creation of analysis supplements.Replace 'ADQRS Long_Name' and 'ADQRS Short_Name' with the long and short name of the measure that the supplement is being created for.Replace royal blue text with information pertaining to the measure the supplement is being created for. Delete royal blue text which does not apply to the new measure. Unless otherwise noted, text in black applies to all QRS Questionnaire Supplements and should not be deleted.Remove all information blocks, except for the one immediately below this called 'Information for Reviewers'.
Keep changes in blue for ease throughout internal and public review. Once the supplement has gone thru public review and all comments are resolved, change all text color to black except for hyperlinks.
Info |
---|
title | Information for Reviewers |
---|
|
Text in black is part of the template used to create this document and is not under review. Please review the blue text; this text represents the changes made to the template that are specific to this QRS instrument. |
Page properties |
---|
Title | Acute Physiology and Chronic Health Evaluation II Clinical Classification (APACHE II) |
---|
CDISC Reference | Clinical Classification Supplement to the Analysis Data Model Implementation Guide |
---|
QRS Short Name | APACHE II |
---|
ADQRS Permission Status | Public Domain |
---|
Team | CDISC ADaM Questionnaires, Ratings, and Scales (QRS) Subteam |
---|
Supplement Version | 1.0 (or higher as appropriate when doing a supplement revision)
|
---|
Status | DRAFT (or "REVISION DRAFT" or "FINAL", as appropriate). Status will not be considered "Final" until the supplement is ready to be sent for publication. |
---|
Date | 2022 (date current version released, regardless of status) |
---|
Notes | This supplement is intended to be used with other CDISC user guides for specific therapeutic/disease areas and follows the CDISC Analysis Data Model Implementation Guide. Naming conventions follow ADaMIG v1.1 or higher. |
---|
Revision History
Date | Version |
---|
2022 (update whenever text is modified below, even during development) | 1.0 Draft |
© 2022 Clinical Data Interchange Standards Consortium, Inc. All rights reserved.
1 General Considerations
Information for Reviewers |
|
Text in black is part of the template used to create this document and is not under review. Please review the blue text; this text represents the changes made to the template that are specific to this QRS instrument. |
Page properties |
---|
Title | Acute Physiology and Chronic Health Evaluation II Clinical Classification (APACHE II) |
---|
CDISC Reference | Clinical Classification Supplement to the Analysis Data Model Implementation Guide |
---|
QRS Short Name | APACHE II |
---|
ADQRS Permission Status | Public Domain |
---|
Team | CDISC ADaM Questionnaires, Ratings, and Scales (QRS) Subteam |
---|
Supplement Version | 1.0 (or higher as appropriate when doing a supplement revision)
|
---|
Status | DRAFT (or "REVISION DRAFT" or "FINAL", as appropriate). Status will not be considered "Final" until the supplement is ready to be sent for publication. |
---|
Date | 2024-02-20 |
---|
Notes | This supplement is intended to be used with other CDISC user guides for specific therapeutic/disease areas and follows the CDISC Analysis Data Model Implementation Guide. Naming conventions follow ADaMIG v1.1 or higher. |
---|
|
Revision History
Date | Version |
---|
2024-02-20 | 1.0 Draft |
© 2024 Clinical Data Interchange Standards Consortium, Inc. All rights reserved.
1 General Considerations
This section describes the implementation of the analysis dataset for QRS instruments as based on the Basic Data Structure (BDS) described in the Analysis Data Model Implementation Guide (ADaMIG). The ADaMIG can be found on the CDISC website at https://www.cdisc.org/standards/foundational/adam. The BDS was chosen as the model for analysis datasets of QRS instruments because it supports a wide variety of analyses, including summaries of total score by timepoint as well as change from baseline by timepoint. This data structure allows the ADaM variables PARAM and PARAMCD to come directly from Study Data Tabulation Model (SDTM) variables RS.RSTEST and RS.RSTESTCD, respectively, for individually captured items, thus ensuring traceability between SDTM and ADaM data. If other analyses are required that are not supported by the BDS, then consideration would be needed as to the appropriate structure. Analysis requirements always drive the design of the analysis datasets.
This ADaM supplement is based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) Clinical Classification Supplement Version 2.0 to the SDTM Implementation Guide for Human Clinical Trials (SDTMIG).
Note that source SDTM score values may not be suitable for analysis because the values may need to be imputed or transformed. In addition, recalculation of collected values may be needed per analysis rules. In these cases, the derivation of AVAL may not be a simple copying of RS.RSSTRESN.
These specific analysis implementation details for the APACHE II are meant to be used in conjunction with ADaMIG. All completed questionnaires, ratings, and scales documentation can be found on the CDISC website at: This section describes the implementation of the analysis dataset for QRS instruments as based on the Basic Data Structure (BDS) described in the Analysis Data Model Implementation Guide (ADaMIG). The ADaMIG can be found on the CDISC website at https://www.cdisc.org/standards/foundational/adam. The BDS was chosen as the model for analysis datasets of QRS instruments because it supports a wide variety of analyses, including summaries of total score by timepoint as well as change from baseline by timepoint. This data structure allows the ADaM variables PARAM and PARAMCD to come directly from Study Data Tabulation Model (SDTM) variables RS.RSTEST and RS.RSTESTCD, respectively, for individually captured questions, thus ensuring traceability between SDTM and ADaM data. If other analyses are required that are not supported by the BDS, then consideration would be needed as to the appropriate structure. Analysis requirements always drive the design of the analysis datasets.
This ADaM supplement is based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) Clinical Classification Supplement Version 1.1 to the SDTM Implementation Guide for Human Clinical Trials (SDTMIG).
Note that source SDTM score values may not be suitable for analysis because the values may need to be imputed or transformed. In addition, recalculation of collected values may be needed per analysis rules. In these cases, the derivation of AVAL may not be a simple copying of RS.RSSTRESN.
...
qrs.
1.1 Representations and Warranties, Limitations of Liability, and Disclaimers
This document is a supplement to the ADaMIG and is covered under Appendix C of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix C of the ADaMIG for a complete version of this material.
CDISC does not endorse any QRS instrument and does not specify how to conduct clinical assessments, protocols, or analyses. CDISC disclaims any liability for your use of this material.
1.2 Copyright Status
CDISC believes this instrument to be in the public domain, but you should perform your own assessment. CDISC has included the APACHE II in the CDISC library of QRS data standards supplements. There may be many versions of this instrument in the public domain or copyrighted. CDISC has chosen to use the version attached to the QRS supplement to the SDTMIG, and the QRS supplement to the ADaMIG is based on the same version.
Note: CDISC Controlled Terminology is maintained by National Cancer Institute (NCI) Enterprise Vocabulary Services (EVS). The most recent versions of the SDTM and ADaM controlled terminologies should be accessed through the CDISC website (https://www.cdisc.org/
...
standards/
...
terminology).
1.
...
3 Known Issues
The Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity of disease measurement and mortality estimation tool for adult subjects applied within 24 hours of admission to an intensive care unit (ICU). The instrument's intended use is for newly admitted subjects to the ICU. The instrument consists of individual items that are summed to create a total score. This instrument is generally collected once at Screening/Baseline. The total score is normally collected as part of the instrument with no instructions provided for handling missing data. In the majority of cases, where APACHE II is only assessed once and the collected total score used as a baseline covariate, the SDTM RS domain may be sufficient to support the analysis requirements. If this is the case, a variable in ADSL copied directly from a result/value in SDTM may be sufficient to support analysis needs. Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | ADQRS-325 |
---|
|
The APACHE II total score is designed as a mortality prediction tool. It is not intended to influence the medical management or care of subjects during their ICU stay or to be calculated sequentially to show improvement or effect of interventions. The worst values recorded during the initial 24 hours in the ICU are recommended to be used in calculation of the total score but the measurements initially recorded during the subject’s admission can be used for practical reasons.
Although the APACHE II total score is the most widely used ICU mortality prediction score, it has a number of limitations and shortcomings. The total score is not intended to be applied to specific populations such as liver failure or HIV subjects and is not accurate when dealing with subjects transferred from another unit or another hospital. Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | ADQRS-326 |
---|
|
The APACHE II total score must be recalibrated before it can be used in a population other than the general ICU population. Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | ADQRS-327 |
---|
|
ICU prediction scores in general need to be periodically recalibrated to reflect changes and improvements in practice and subject demographics. Be sure to discuss the use of this instrument with the appropriate regulatory authorities.
2 Rules and References
The primary source used in the development of this supplement is Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system [1]. Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | ADQRS-328 |
---|
|
...
This document is a supplement to the ADaMIG and is covered under Appendix C of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix C of the ADaMIG for a complete version of this material.
CDISC does not endorse any QRS instrument and does not specify how to conduct clinical assessments, protocols, or analyses. CDISC disclaims any liability for your use of this material.
Include this line only for supplements that the US FDA will be reviewing: Although the United States Food and Drug Administration (US FDA) has provided input with regard to this supplement, this input does not constitute US FDA endorsement of any particular instrument.
1.2 Copyright Status
CDISC believes this instrument to be in the public domain, but you should perform your own assessment. CDISC has included the APACHE II in the CDISC library of QRS data standards supplements. There may be many versions of this instrument in the public domain or copyrighted. CDISC has chosen to use the version attached to the QRS supplement to the SDTMIG, and the QRS supplement to the ADaMIG is based on the same version.
Note: CDISC Controlled Terminology is maintained by National Cancer Institute (NCI) Enterprise Vocabulary Services (EVS). The most recent versions of the SDTM and ADaM controlled terminologies should be accessed through the CDISC website (https://www.cdisc.org/standards/terminology).
1.3 Known Issues
The Acute Physiology and Chronic Health Evaluation (APACHE II) is a severity of disease measurement and mortality estimation tool for adult patients typically admitted to intensive care units. The instrument consists of individual items that are summed up to create a total score. This instrument is generally collected once at Screening/Baseline and used as a predictor of mortality rather than an outcome measure. Individual items on this instrument are summed to create a total score but this total score is generally collected as part of the instrument with no instructions provided for handling missing data. In the majority of cases, where APACHE II is only assessed once and the collected total score used as a baseline covariate, the SDTM RS domain may be sufficient to support the analysis requirements.
2 Rules and References
The primary source used in the development of this supplement is the Geriatric Depression Scale web page[1] maintained by Dr. Jerome Yesavage, co-developer of the instrument. It contains scoring instructions and links to multiple language translations. The development of the GDS SHORT FORM is discussed in "Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version"[2] by Drs. Sheikh and Yesavage. Validation and possible interpretations of the GDS SHORT FORM are discussed in "The Short Form of the Geriatric Depression Scale: A Comparison With the 30-Item Form."[3]
All links are valid and referenced information is current as of the date of this ADaMIG QRS supplement. This supplement does not make recommendations for the handling of missing data or adoption of imputation methods.
3 Scoring Software
There is no known publicly available scoring software as of the date of this ADaMIG QRS supplement.
4 Introduction to the Instrument
...
The APACHE II, is II is a severity-of-disease classification system that uses a point score based upon on the initial values of 12 routine physiologic measurements, age, and previous health status to provide a general measure of severity of disease. It was modified from the original 30-item form to focus on items with the highest correlation to depressive symptoms in validation studies, and consists of 15 items, each with possible response options of "YES" or "NO". Note that the “YES” and “NO” responses for SDTM QS.QSORRES are recorded in QS.QSSTRESN based on the instrument's scoring manual, so that a QSSTRESN (and AVAL) value of 0 does not always represent a QSORRES response of "NO", and a QSSTRESN (and AVAL) value of 1 does not always represent a QSORRES response of "YES". As a result, transposition or reversal of question responses is not required. The total score is computed by adding the individual standardized item responses.
Scores for the APACHE II range from 0 to 71, inclusive.
5 Key Data Checks
Each item has a possible value of 0 or 1. The computed total score consists of integer values ranging from 0 to 15.
6 Example
6.1 Background
Analyses based on ADaM datasets may vary depending on the sponsor, therapeutic area, and the needs of regulatory authorities in their decision-making processes. This fictional example is provided for illustrative purposes only. The ADaM dataset describing the analysis results from an instrument is based on the protocol and statistical analysis plan (SAP) for the individual study.
The example dataset described here is intended to support a variety of analyses, ranging from simple univariate summary statistics on both the actual total scores and change in total score from baseline by visit to other types of by-visit and repeated-measure analyses. For that reason, standard ADaM BDS variables such as AVAL (analysis value) and CHG (change from baseline) have been included in the example. In addition, because scores can be classified into categorizations of depression severity, frequency of subjects reporting each category may also be generated.
In the example presented here, it is assumed that the final GDS SHORT FORM analysis dataset (ADGDSSF) contains all of the original records, plus a record for the computed total score for each patient and assessment timepoint. The date of the assessment—and time of the assessment, if collected—should also be included in the dataset. For traceability, raw item-level responses from the SDTM QS.QSORRES variable, stored separately from the analysis variable AVAL, are included. Derivation type (DTYPE) should be used to clearly indicate those records where missing values or other information has been imputed. If useful for analysis, a summary analysis dataset which includes only the computed total score records may also be created.
This example is based on Yesavage's short form English scoring,[1] which states that if 5 or fewer instrument items are missing, the values of the missing items are imputed as the average of the non-missing responses. If the imputation procedure results in a total score that is not a whole number (e.g., 4.5, 10.2), the total score should be rounded up to the next whole number (i.e., round up to a more severe level of depression). For example, if 3 of the 15 items are missing and the total score based on the 12 non-missing items is 4, then impute the value of each of the 3 missing items as 4/12 = 1/3, for a total score of 4 + (3 * 1/3) = 4 + 1 = 5 (see the Parameter Value Level List - ADGDSSF [AVAL] table). If more than 5 items on the GDS SHORT FORM are missing, no item-level imputation is performed and a total score is not calculated.
6.2 Example Analysis Dataset, Variable and Value-level Metadata
. Scores range from 0 to 71 and higher scores correspond to more severe disease and a higher risk of death. The composite score is based on findings represented in other SDTM domains such as Laboratory Test Results (LB) and Vital Signs (VS).
5 Key Data Checks
The computed total score consists of integer values ranging from 0 to 71. The classification system consists of 11 physiology measures based on a numeric rating scale 0 to 4, Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | ADQRS-329 |
---|
|
where 0 reflects values within the normal range and an increase in the numeric rating scale represents an increase in the abnormality of the physiology measure in either the high or low direction. For Serum Creatinine, the measure is assessed on the same scale but double points are assigned for subjects with acute renal failure. The measure evaluating extent of impaired consciousness is calculated as 15 minus the Glasgow Coma Scale (GCS) Score, so that lower scores indicate mild or no impairment and higher scores represent more severe impairment (possible head and/or central nervous system injury) and range from 0 to 12. Chronological age is divided into age groups which are assigned values of 0, 2, 3, 5, or 6 Jira |
---|
showSummary | false |
---|
server | Issue Tracker (JIRA) |
---|
serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
---|
key | ADQRS-330 |
---|
|
.
For subjects with a history of severe organ system insufficiency or who are immunocompromised, a numeric rating of 2 or 5 is assigned for chronic health points, where 2 is assigned “for elective postoperative subjects” and 5 is assigned “for nonoperative or emergency postoperative subjects”. For subjects who do not have a history of severe organ system insufficiency or who are not immunocompromised, a NOT DONE record may be retained from the source RS domain with the conditional branching flag (RSCBRFL="Y") populated. Additionally, a sponsor may choose to set AVAL=0 for subjects who do not meet the criteria for assigning chronic health points. This decision must be clearly documented, as the analysis value of 0 is logically derived or implied.
6 Example
6.1 Background
Analyses based on ADaM datasets may vary depending on the sponsor, therapeutic area, and the needs of regulatory authorities in their decision-making processes. This fictional example is provided for illustrative purposes only. The ADaM dataset describing the analysis results from an instrument is based on the protocol and statistical analysis plan (SAP) for the individual study.
The example dataset described here is intended to support a variety of analyses, ranging from simple univariate summary statistics on the actual total scores to other types of by-visit and repeated-measure analyses. For that reason, standard ADaM BDS variables such as AVAL (analysis value) have been included in the example. In addition, although not illustrated in the example, the APACHE II total score can be divided into categories (e.g., <17, >=17) reflecting disease severity or risk of death, and the frequency of subjects reporting in each category may be generated or used for analysis.
In the example presented here, it is assumed that the final APACHE II analysis dataset (ADAPCH) contains all of the original records, plus a record for the computed total acute physiology score and a record for the computed total APACHE II for each subject and assessment timepoint. The date of the assessment—and time of the assessment, if collected—should also be included in the dataset. For traceability, raw item-level responses from the SDTM RS.RSORRES variable, stored separately from the analysis variable AVAL, are included. Derivation type (DTYPE) should be used to clearly indicate records where missing values have been imputed using sponsor-defined imputation methods. If useful for analysis, a summary analysis dataset which includes only the computed total score records may also be created.
6.2 Example Analysis Dataset, Variable and Value-level Metadata
The ADAPCH Dataset Metadata table shows an example of how the APACHE II may be implemented in ADaM. The ADGDSSF Dataset Metadata table shows an example of how the GDS SHORT FORM may be implemented in ADaM. The dataset metadata is a recommendation for the dataset name, label, structure, and keys. These can be modified for sponsor-specific standards and analyses. (Use the table macros to insert these tables. they reside at the end of the document like an appendix)
Definexmltable |
---|
Level | Dataset |
---|
Purpose | Analysis |
---|
Name | ADGDSSFADAPCH |
---|
|
Dataset | Label | Structure | Keys | Class |
---|
ADAPCH | APACHE II Analysis Dataset | ADGDSSF | Geriatric Depression Scale SF Analysis | 1 record per subject per timepoint analysis visit per parameter. | USUBJID, AVISITN, ADT, PARAMN | BASIC DATA STRUCTURE |
|
The ADGDSSF ADAPCH Variable Metadata table contains an example of analysis variable metadata for a subset of possible variables available for the GDS SHORT FORMAPACHE II. Example value-level metadata are found in the Parameter Value Level List - ADGDSSF [AVAL] metadata table. Derivations for AVALCAT1 and AVAL included in the Derivation column were obtained from the scoring instructions for the GDS SHORT FORM[1] and are described in the Introduction to the Instrument section of this supplement. The ADGDSSF Variable ADAPCH metadata table. The ADAPCH Variable Metadata table does not include all of the possible variables that may be present in the Subject-Level Analysis Dataset (ADSL) and copied to the BDS structure analysis dataset, with the exception of the required STUDYID and USUBJID. For a complete list of available ADSL variables, consult the ADaMIG. Some ADSL variables (e.g., INVNAMREGION1) were included in this example for stratification, and are not required. Additional Additional covariates or other variables may be added as needed for analysis. Common BDS variables such as BASE and CHG have been omitted from the example as the majority analyses of APACHE II do not use these variables. There is no specific ordering of variables recommended in this supplement. The SDTM variables were placed next to the corresponding derived ADaM variables for illustration purposes only.
Update the below table according to the current QRS Short_Name instrument.
Definexmltable |
---|
Definexmltable |
---|
Multiple | true |
---|
Extra | User Notes |
---|
Dataset | ADGDSSFADAPCH |
---|
Level | Variable |
---|
Purpose | Analysis |
---|
|
Variable Name | Variable Label | Type | Controlled Terms | Source | Derivation | User Notes |
---|
STUDYID | Study Identifier | Char |
| QSRS.STUDYID |
|
| USUBJID | Unique Subject Identifier | Char |
| QSRS.USUBJID |
|
| SITEID | Site Identifier | Char |
| ADSL.SITEID |
|
| QSSEQRSSEQ | Sequence Number | Num |
| QSRS.QSSEQRSSEQ |
| QSSEQ is RSSEQ is included to provide traceability back to SDTM. | ASEQ | Analysis Sequence Number | Num |
| | After sorting by key variables, renumber all the records from 1 to n within a subject. | Provides a sequence number to derived rows which are not present in QSSEQRSSEQ. | ITTFL | Intent-to-Treat Population Flag | Char | “Y”, “N” | ADSL.ITTFL |
| Conditional; must include at least 1 population flag. | TRTP | Planned Treatment | Char | "DRUG A + SOC", "SOC" |
|
| Derivation should be defined by sponsor according to analysis needs. Conditional; should include at least 1 treatment variable (e.g., TRTP, TRTA, TRTSEQP, TRT01P). | PARAM | Parameter | Char | | |
| See Parameter Value Level List - ADAPCH table QS.QSTEST for responses to individual questions copied from SDTM. Set PARAM to "GDS02- Total Score - Analysis" for the derived total score. |
| PARAMCD | Parameter Code | Char | | QS.QSTESTCD for responses to individual questions copied from SDTM. Set PARAMCD to "GDS02TS" for the derived total score. | | |
| See Parameter Value Level List - ADAPCH table. |
| PARAMN | Parameter Number | PARAMN | Parameter Number | Num |
| | Number of the item in the order it appears on the form; assign a higher value to the derived total score record. |
| PARCAT1 | Parameter Category 1 | Char | "GDS SHORT FORMAPACHE II" | | Set to QSRS.QSCAT RSCAT for records that come directly from SDTM and "GDS SHORT FORMAPACHE II" for any derived records such as total scores or last observed value (LOV). |
| VISIT | Visit Name | Char |
| QSRS.VISIT |
| QSRS.VISIT included for traceability. | VISITNUM | Visit Number | Num |
| QSRS.VISITNUM |
| QSRS.VISITNUM included for traceability. | AVISIT | Analysis Visit | Char |
|
|
| AVISIT represents the analysis visit for the record. Refer to the SAP for additional details. | AVISITN | Analysis Visit (N) | Num |
|
| A numeric representation of AVISIT. |
| QSDTCRSDTC | Date/Time of Finding | Char |
| QSRS.QSDTCRSDTC |
| QSRS.QSDTC RSDTC included for traceability. | ADT | Analysis Date | Num |
|
| Date portion of QSRS.QSDTC RSDTC converted to numeric and displayed in a format such as DATE9. For derived total score records where PARAMCD ="GDS02TS"in ("APCH1TPS" "APCH1TS"), this information will be copied from the individual records that comprise that instrument. |
| ADY | Analysis Relative Day | Num |
| | ADT-ADSL.TRTSDT+1 if ADT≥TRTSDT; else, ADT-ADSL.TRTSDT if ADT<TRTSDT. | This derivation is for example only. | QSORRESRSORRES | Finding in Original Units | Char |
| QSRS.QSORRESRSORRES |
|
| AVALRSORRESUAnalysis Value | Original Units | Num | See Parameter Value Level List - ADGDSSF table. | Char |
| RS.RSORRESU |
|
| RSCBRFL | Conditionally Branched Item Flag | AVALCAT1 | Analysis Value Category 1 | Char | "Normal”, "Possible Depression", "Likely Depression", | If AVAL<5, then AVALCAT1="Normal"; If 5<AVAL<10, then AVALCAT1="Possible Depression"; If AVAL>10, then AVALCAT1="Likely Depression". | Source: Yesavage[1] | BASE | Baseline Value | Num | BASE=AVAL where ABLFL="Y". | Only the derived total score records where PARAMCD="GDS02TS" should have BASE populated in this example. | CHG | Change from Baseline | Num | CHG=AVAL-BASE | Only populate for post-baseline total score records in this example (where PARAMCD="GDS02TS" and ADY>1). | DTYPE | Derivation Type | Char | “AVERAGE”, “LOV” | For PARAMCD="GDS02TS": If the scoring instructions on the GDS SHORT FORM web page are followed and 1-5 responses are missing on the instrument, then populate DTYPE with "AVERAGE". Other missing value imputations for individual questions are indicated with DTYPE="AVERAGE", and imputations for a completely missing total score and a derived endpoint record can be indicated with DTYPE="LOV" in this example. Otherwise, leave NULL. | ABLFL | Baseline Record Flag | Char | “Y” | Set ABLFL="Y" on the record defined as the baseline value. This flag will only be populated on the derived total score records (PARAMCD="GDS02TS") in this example. | ANL01FL | Analysis Record Flag 01 | Char | “Y” | Set ANL01FL="Y" on derived total score records (PARAMCD="GDS02TS") associated with scheduled visits in this example (VISIT is not of the form "UNSCHEDULED XXX.XX"). | Permissible and useful for selecting records that are used in SAP-specified analyses. | INVNAM | Investigator Name | Char | ADSL.INVNAM | Permissible if needed for analysis. |
|
The following SDTM variables can be copied into the corresponding equivalent ADaM variables. Note that the SDTM variable values can be converted to mixed case as needed for analysis purposes. The Action column shown in the table below is optional, and can be removed if all values for these variables are simply copied over from SDTM. For supplements where the SDTM values are modified, please provide a description of what was done. For example, in the CHART-SF supplement, PARAM/PARAMCD are modified by replacing the version number with 'A', so that action is described here as "Harmonizing the two methods of administration (Paper and Interview) for individual items. Fragment representing version number is changed to an 'A'."
...
SDTM Variable
...
ADaM Variable
...
QSTESTCD
...
PARAMCD
...
QSTEST
...
PARAM
...
QSCAT
...
PARCAT1
...
QSSTRESN
...
AVAL
...
All controlled terminology for instruments in both SDTM and ADaM is associated with a specific version of the instrument. When integrating responses from an instrument across studies, it is important to know which version of the instrument was used for each study. When multiple versions of the same instrument exist in an integration, a pooled analysis of responses across different versions can only be performed if determined to be clinically and statistically acceptable. In that case, sponsor-defined terminology, similar to CDISC Controlled Terminology but without the reference to a specific version, should be used for PARAMCD, PARAM and PARCATy.
...
Extra | User Notes |
---|
Dataset | ADGDSSF |
---|
Level | Value |
---|
Purpose | Analysis |
---|
Name | AVAL |
---|
Y" | SUPPRS.RSCBRFL |
| Represents that this item was "NOT DONE" due to conditional branching. AVAL is not populated on this record for this item due to conditional branching. | AVAL | Analysis Value | Num |
|
| See Parameter Value Level List - ADAPCH table. |
| DTYPE | Derivation Type | Char | "WOC" | |
|
| ABLFL | Baseline Record Flag | Char | “Y” | | Set ABLFL="Y" on the record defined as the baseline value. This flag will only be populated on the derived acute physiology and APACHE II total score records (PARAMCD in ("APCH1TPS" "APCH1TS")) in this example. |
| COUNTRY | Country | Char |
| ADSL.COUNTRY |
| Permissible if needed for analysis. Generally represented using ISO 3166-1 Alpha-3. Note that regulatory agency specific requirements (e.g., US FDA) may require other terminologies; in such cases, follow regulatory requirements. | REGION1 | Geographic Region 1 | Char |
| ADSL.REGION1 |
| Permissible if needed for analysis. | REGION1N | Geographic Region 1 (N) | Num |
| ADSL.REGION1N |
| Permissible if needed for analysis. |
|
The following SDTM variables can be copied into the corresponding equivalent ADaM variables. Note that the SDTM variable values can be converted to mixed case as needed for analysis purposes.
Metadataspec |
---|
SDTM Variable | ADaM Variable | RSTESTCD | PARAMCD | RSTEST | PARAM | RSCAT | PARCAT1 | RSSTRESN | AVAL |
|
All controlled terminology for instruments in both SDTM and ADaM is associated with a specific version of the instrument. When integrating responses from an instrument across studies, it is important to know which version of the instrument was used for each study. When multiple versions of the same instrument exist in an integration, a pooled analysis of responses across different versions can only be performed if determined to be clinically and statistically acceptable. In that case, sponsor-defined terminology, similar to CDISC Controlled Terminology but without the reference to a specific version, should be used for PARAMCD, PARAM and PARCATy.
Definexmltable |
---|
Extra | User Notes |
---|
Dataset | ADAPCH |
---|
Level | Value |
---|
Purpose | Analysis |
---|
Name | AVAL |
---|
|
Variable | Where | Type | Controlled Terms | Source | Derivation | User Notes |
---|
AVAL | PARAMCD NOTIN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis)) | Num |
| | Set AVAL=RS.RSSTRESN. | The analysis value is the result copied from SDTM. | AVAL | PARAMCD EQ "APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis) | Num |
| | The sum of RS.RSSTRESN for RS.RSTESTCD in ("APCH101"-"APCH112") if no items are missing. Note that among item pairs RSTESTCD in ("APCH105A", "APCH105B") as well as RSTESTCD in ("APCH106A", "APCH106B") only one item is expected to be answered and not both, respectively. | The expectation is that issues pertaining to conditional branching (e.g., both items answered) are queried and fixed in SDTM RS. If this is not possible, the statistician will provide guidance and documentation of how to conduct the analysis given the circumstance (e.g. worst score).
| AVAL | PARAMCD EQ "APCH1TS" (APCH1-Total APACHE II Score - Analysis) | Num |
| | The sum of RS.RSSTRESN for RS.RSTESTCD in ("APCH101"-"APCH112") and "APCH114", "APCH115" if no items are missing. Note that among item pairs RSTESTCD in ("APCH105A", "APCH105B") as well as RSTESTCD in ("APCH106A", "APCH106B") only one item is expected to be answered and not both, respectively. If a subject dies on or before Day 15, they are assigned the highest observed APACHE II score of any of the subjects at any time during the trial for their Total APACHE II Score at Day 15 (Day of Discharge). | The assignment of the highest observed APACHE II score is for illustration purposes only and not meant as a recommendation. | PARAMCD | PARAMCD NOTIN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis)) | Char | APCH1TC | | See CDISC Controlled Terminology for Clinical Classification Test Codes. RS.RSTESTCD for responses to individual items copied from SDTM. |
| PARAMCD | PARAMCD IN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis)) | Char | APCH1PC | | See CDISC Controlled Terminology for Parameter Codes. |
| PARAM | PARAMCD NOTIN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis)) | Char | APCH1TN | | See CDISC Controlled Terminology for Clinical Classification Test Names. RS.RSTEST for responses to individual items copied from SDTM. |
| PARAM | PARAMCD IN ("APCH1TPS" (APCH1-A: Total Acute Physiology Score - Analysis), "APCH1TS" (APCH1-Total APACHE II Score - Analysis)) | Char | APCH1PN | | See CDISC Controlled Terminology for Parameter Names. |
|
|
6.3 Example Analysis Dataset
The APACHE II Analysis Dataset tables below show the terminology and variables for implementing the example analysis dataset for this instrument in the BDS. This specific example is taken from a Phase II, randomized, controlled, open label multi-center study to assess the efficacy and safety of Drug A for the treatment of SARS-CoV-2 infected subjects with COVID-19 pneumonia and impaired respiratory function. The primary outcome measure is APACHE II Severity of Disease Score on Day 15 or on the Day of Discharge (whichever is earlier). This measure compares "Drug A + SOC" with "SOC" (SOC = Standard of Care).
In this example, the APACHE II was measured within 24 hours of ICU admission, on or before Day 1 (prior to implementation of treatment), Day 7, and Day 15 or on the day of discharge (whichever was earlier). In the example, as per the SAP, subjects who died on Day 15 or earlier were assigned the highest observed APACHE II score of any of the subjects at any time during the trial (worst case imputation for deaths). This imputation method is for example purposes only and not meant to be a recommendation nor considered a common practice. Missing data values for the parameters required for the derivation of the APACHE II score were replaced by the last available assessment. Item level imputation, in this example, is handled by the investigators and/or clinicians at the site and is considered source data, already captured in SDTM. SOC included a variety of supportive therapies that ranged from the administration of supplementary oxygen to full intensive care support, alongside the use of antiviral treatment, convalescent plasma, corticosteroids, antibiotics or other agents.
In the example, the
...
Variable
...
Where
...
Type
...
Controlled Terms
...
Source
...
Derivation
...
User Notes
...
AVAL
...
PARAMCD NE "GDS02TS" (GDS02- Total Score - Analysis)
...
Num
...
AVAL
...
PARAMCD EQ "GDS02TS" (GDS02- Total Score - Analysis)
...
Num
...
The sum of QS.QSSTRESN for QS.QSTESTCD in ("GDS0201"-"GDS0215") if no question are missing.
- If ≤5 responses are missing on an instrument, then AVAL is 15*(sum of non-missing QS.QSSTRESN for QS.QSTESTCD in ("GDS0201"-"GDS0215")/number of non-missing questions for QS.QSTESTCD in ("GDS0201"-"GDS0215"). If the result is a fraction, round up to the nearest integer.
- If >5 responses are missing, do not calculate a total score, and do not create a total score record.
6.3 Example Analysis Dataset
The GDS SHORT FORM Summary Analysis Dataset table shows the terminology and variables for implementing the example analysis dataset for this instrument in the BDS. This specific example is taken from a multicenter, randomized, double-blind, active-controlled parallel design study conducted in elderly patients with major depressive disorder. The purpose of the analysis is to compare the effect of Drug A to Drug B on depression in elderly patients using the GDS SHORT FORM to construct an endpoint. All analyses are conducted on an intent-to-treat basis, and the planned duration of treatment is 5 months. The baseline measurement is defined as the last non-missing value collected at or prior to the start of treatment; change from the last non-missing post-baseline value to baseline is used to construct an endpoint. The SAP specifies that planned collected visits, including baseline measurements, are to be used in analyses and displays of results. In fact, whereas no unscheduled visits appear only in listings. The total score records for 1 subject were collected at 3 visits, plus a derived last observed value (LOV) endpoint record for the GDS SHORT FORM. Visit 1 is remapped to AVISIT = "BASELINE". There are 2 visits at AVISIT = "VISIT 2". However, because 1 visit was unscheduled, it is not used in the analysis and the ANL01FL value is null. Visits 5 and 6 are missing because the subject discontinued early due to an adverse event unrelated to treatment.
Update the below dataset and title according to the current QRS Short_Name instrument.
GDS SHORT FORM Complete Analysis Dataset
exist in the source data. If the planned physiology assessment is not done or invalid, the investigator may choose to use a previous or repeat assessment of that parameter as the value at that visit for the scoring of APACHE II. The records for 2 subjects are shown in the example datasets. The data for 3 visits is shown for the first subject, with no missing data. The data for 1 visit is shown for the second subject, who died before the Day 15 (Day of Discharge) Visit so the APACHE II total score is imputed to the worst case value of any subjects across any timepoints at that visit. Note that the worst case value is not shown in the sample data.
APACHE II Complete Analysis Dataset
The APACHE II Complete Analysis Dataset table shows all of the individual item The GDS SHORT FORM Complete Analysis Dataset table shows all of the individual question responses for this example, as well as the computed total Acute Physiology score and the computed total APACHE II score. This example is considered to be the final analysis dataset for submission. Computed total scores can appear after the individual item responses, with appropriate labels for identification.
Dataset wrap |
---|
|
Dataset2 |
---|
QSSEQRSSEQ | ASEQ | ITTFL | TRTP | PARAM | PARAMCD | PARAMN | PARCAT1 | VISIT | VISITNUM | AVISIT | AVISITN |
---|
QSDTCQSORRESAVALAVALCAT1BASE | CHGANL01FLINVNAM101101GDS02-Satisfied With Life | APCH1-Temperature - Rectal | APCH101 | GDS0201GDS SHORT FORM | VISIT 1BASELINE2012-11-16 | 2020-06-29 | 29JUN2020 | 1 | 38.5-38.9 | C | 16NOV2012YES0 | DR. JOHN SMITH101101GDS02-Dropped Activities and Interests | APCH1-Mean Arterial Pressure | APCH102 | GDS0202GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012 | 110-129 | mmHg |
| 2 |
|
| USA | North America | YESDR. JOHN SMITH | 101101GDS02-Life Is Empty | GDS0203GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012NO | 0 | | 70-109 | beats/min |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02Bored OftenGDS0204GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012YESDR. JOHN SMITH |
|
| USA | North America | 1 | 5 | STUDYX | X- | 101101GDS02-Good Spirits Most of Time | + SOC | APCH1-Oxygenation: A-aDO2 | APCH105A | GDS0205GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012NODR. JOHN SMITH | 101101GDS02-Afraid of Something Bad Happening | APCH1-Oxygenation: PaO2 | APCH105B | GDS0206GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012YESDR. JOHN SMITH |
|
| USA | North America | 1 | 7 | STUDYX | X- | 101101GDS02-Feel Happy Most of Time | APCH1-Arterial pH | APCH106A | GDS0207GDS SHORT FORM | VISIT 1BASELINE2012-11-16 | 16NOV2012 | 1 | NO | 1 | DR. JOHN SMITH | 2020-06-29 | 29JUN2020 | 1 | 7.15-7.24 |
|
| 3 |
|
| USA | North America | 1 | 8 | STUDYX | X- | 101101GDS02-Often Feel Helpless | GDS0208GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012YESDR. JOHN SMITH101101GDS02-Prefer to Stay Home | APCH1-Serum Sodium | APCH107 | GDS0209GDS SHORT FORM | VISIT 1BASELINE2012-11-16 | 2020-06-29 | 29JUN2020 | 1 | 150-154 | mmol/L | 16NOV2012NO0 | DR. JOHN SMITH101101GDS02Memory ProblemsGDS0210GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012 | 3.5-5.4 | mmol/L |
| 0 |
|
| USA | North America | YESDR. JOHN SMITH | 101101GDS02-Wonderful to Be Alive | APCH1-Serum Creatinine | APCH109 | GDS0211GDS SHORT FORM | VISIT 1BASELINE2012-11-16 | 16NOV2012 | 1 | NO | 1 | 2020-06-29 | 29JUN2020 | 1 | <0.6 | mg/dL |
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02Feel WorthlessGDS0212GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012YES | 1 | DR. JOHN SMITH | 20-29.9 | % |
| 2 |
|
| USA | North America | 1 | 13 | STUDYX | X- | 101101GDS02-Feel Full of Energy | APCH1-White Blood Count | APCH111 | GDS0213GDS SHORT FORM | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-06-29 | 29JUN2020 | VISIT 1BASELINE | 0 | 2012-11-16 | 16NOV2012 | 1 | YES | 0 | 20-39.9 | 10^9/L |
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Feel Hopeless | APCH1-15 Minus Glasgow Coma Score | APCH112 | GDS0214GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012YESDR. JOHN SMITH | 101101GDS02-Most People Better Off Than You | APCH1-A: Total Acute Physiology Score | APCH113 | GDS0215GDS SHORT FORM | VISIT 1BASELINE2012111616NOV2012NO0 | DR. JOHN SMITH101101GDS02APCH1-A: Total Acute Physiology Score - Analysis | GDS02TSGDS SHORT FORM | VISIT 1BASELINE2012111616NOV201210Possible Depression10YYDR. JOHN SMITH | 101101GDS02-Satisfied With Life | APCH1-B: Age Points | APCH114 | 17 | APACHE II | SCREENING | GDS0201GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | YES | 0 | Baseline | 0 | 2020-06-29 | 29JUN2020 | 1 | 45-54 | YEARS |
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Dropped Activities and Interests | GDS0202 | 2 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 0 | APCH1-C: Chronic Health Points | APCH115 | 18 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-06-29 | 29JUN2020 | 1 | for elective postoperative patients |
|
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Life Is Empty | GDS0203 | 3 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 0 | APCH1-Total APACHE II Score | APCH116 | 19 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-06-29 | 29JUN2020 | 1 | 22 |
|
| 22 |
|
| USA | North America | 1 | DR. JOHN SMITH10110119 | GDS02-Bored Often | GDS0204 | 4 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | YES | 1 | DR. JOHN SMITH | + SOC | APCH1-Total APACHE II Score - Analysis | APCH1TS | 20 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-06-29 | 29JUN2020 | 1 |
|
|
| 22 |
| Y | USA | North America | 1 | 21 | STUDYX | X- | 10110120GDS02-Good Spirits Most of Time | GDS0205 | 5 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 1 | APCH1-Temperature - Rectal | APCH101 | 1 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 38.5-38.9 | C |
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH10110121GDS02-Afraid of Something Bad Happening | GDS0206 | 6 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | YES | 1 | DR. JOHN SMITH | APCH1-Mean Arterial Pressure | APCH102 | 2 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 70–109 | mmHg |
| 0 |
|
| USA | North America | 1 | 23 | STUDYX | X- | 10110122GDS02-Feel Happy Most of Time | GDS0207 | 7 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 1 | APCH1-Heart Rate | APCH103 | 3 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 70-109 | beats/min |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH10110123GDS02-Often Feel Helpless | GDS0208 | 8 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | YES | 1 | APCH1-Respiratory Rate | APCH104 | 4 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 25-34 | breaths/min |
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH10110124GDS02-Prefer to Stay Home | GDS0209 | 9 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 0 | + SOC | APCH1-Oxygenation: A-aDO2 | APCH105A | 5 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 |
|
| Y |
|
|
| USA | North America | 1 | DR. JOHN SMITH10110125GDS02-Memory Problems | GDS0210 | 10 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 0 | APCH1-Oxygenation: PaO2 | APCH105B | 6 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 61-70 | mmHg |
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH10110126GDS02-Wonderful to Be Alive | GDS0211 | 11 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 1 | DR. JOHN SMITH | APCH1-Arterial pH | APCH106A | 7 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 7.25-7.32 |
|
| 2 |
|
| USA | North America | 1 | 28 | STUDYX | X- | 10110127GDS02Feel WorthlessGDS021212 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | YES | 1 | DR. JOHN SMITH8 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 |
|
| Y |
|
|
| USA | North America | 1 | 29 | STUDYX | X- | 10110128GDS02-Feel Full of Energy | GDS0213 | 13 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | YES | 0 | APCH1-Serum Sodium | APCH107 | 9 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 150-154 | mmol/L |
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH10110129GDS02-Feel Hopeless | GDS0214 | 14 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | YES | 1 | DR. JOHN SMITH | APCH1-Serum Potassium | APCH108 | 10 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 3.5-5.4 | mmol/L |
| 0 |
|
| USA | North America | 1 | 31 | STUDYX | X- | 10110130GDS02-Most People Better Off Than You | GDS0215 | 15 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | NO | 0 | APCH1-Serum Creatinine | APCH109 | 11 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 0.6-1.4 | mg/dL |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02- Total Score - Analysis | GDS02TS | 16 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 2012-12-15 | 15DEC2012 | 30 | 8 | Possible Depression | 10 | -2 | Y | DR. JOHN SMITHAPCH1-Hematocrit | APCH110 | 12 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 20-29.9 | % |
| 2 |
|
| USA | North America | 1 | 33 | STUDYX | X- | 101101GDS02-Satisfied With Life | GDS0201 | 1 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 0 | APCH1-White Blood Count | APCH111 | 13 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 15-19.9 | 10^9/L |
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Dropped Activities and Interests | GDS0202 | 2 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | NO | 0 | APCH1-15 Minus Glasgow Coma Score | APCH112 | 14 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 1 |
|
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Life Is Empty | GDS0203 | 3 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 1 | APCH1-A: Total Acute Physiology Score | APCH113 | 15 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 10 |
|
| 10 |
|
| USA | North America | 1 | DR. JOHN SMITH10110134 | GDS02-Bored Often | GDS0204 | 4 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 1 | + SOC | APCH1-A: Total Acute Physiology Score - Analysis | APCH1TPS | 16 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 |
|
|
| 10 |
|
| USA | North America | 1 | DR. JOHN SMITH10110135GDS02-Good Spirits Most of Time | GDS0205 | 5 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | NO | 1 | APCH1-B: Age Points | APCH114 | 17 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 45-54 | YEARS |
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH10110136GDS02-Afraid of Something Bad Happening | GDS0206 | 6 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 1 | DR. JOHN SMITH | APCH1-C: Chronic Health Points | APCH115 | 18 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | for elective postoperative patients |
|
| 2 |
|
| USA | North America | 1 | 39 | STUDYX | X- | 10110137DRUG A | GDS02-Feel Happy Most of Time | GDS0207 | 7 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | NO | 0 | | DRUG A + SOC | APCH1-Total APACHE II Score | APCH116 | 19 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 | 14 |
|
| 14 |
|
| USA | North America | 1 | DR. JOHN SMITH10138101 | GDS02-Often Feel Helpless | GDS0208 | 8 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 1 | DR. JOHN SMITH | + SOC | APCH1-Total APACHE II Score - Analysis | APCH1TS | 20 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 2020-07-05 | 05JUL2020 | 7 |
|
|
| 14 |
|
| USA | North America | 1 | 41 | STUDYX | X- | 10110139GDS02-Prefer to Stay Home | GDS0209 | 9 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | NO | 0 | APCH1-Temperature - Rectal | APCH101 | 1 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 36-38.4 | C |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH10110140GDS02-Memory Problems | GDS0210 | 10 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | NO | 0 | APCH1-Mean Arterial Pressure | APCH102 | 2 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 70–109 | mmHg |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH10110141GDS02-Wonderful to Be Alive | GDS0211 | 11 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | NO | 1 | DR. JOHN SMITH | APCH1-Heart Rate | APCH103 | 3 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 70-109 | beats/min |
| 0 |
|
| USA | North America | 1 | 44 | STUDYX | X- | 10110142GDS02Feel WorthlessGDS021212 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 1 | 4 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 12–24 | breaths/min |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH10110143GDS02-Feel Full of Energy | GDS0213 | 13 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 0 | + SOC | APCH1-Oxygenation: A-aDO2 | APCH105A | 5 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 |
|
| Y |
|
|
| USA | North America | 1 | DR. JOHN SMITH10110144GDS02-Feel Hopeless | GDS0214 | 14 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | YES | 1 | APCH1-Oxygenation: PaO2 | APCH105B | 6 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 61-70 | mmHg |
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH10110145GDS02-Most People Better Off Than You | GDS0215 | 15 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | NO | 0 | APCH1-Arterial pH | APCH106A | 7 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 7.33-7.49 |
|
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH10110146GDS02- Total Score - Analysis | GDS02TS | 16 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | UNSCHEDULED 2.01 | 2 | 2012-12-28 | 28DEC2012 | 43 | 9 | Possible Depression | 10 | -1 | DR. JOHN SMITHAPCH1-Serum HCO3 | APCH106B | 8 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 |
|
| Y |
|
|
| USA | North America | 1 | 49 | STUDYX | X- | 101101GDS02-Satisfied With Life | GDS0201 | 1 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 0.46 | AVERAGE | APCH1-Serum Sodium | APCH107 | 9 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 130-149 | mmol/L |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Dropped Activities and Interests | GDS0202 | 2 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 0.46 | AVERAGE | APCH1-Serum Potassium | APCH108 | 10 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 3.5-5.4 | mmol/L |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Life Is Empty | GDS0203 | 3 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | NO | 0 | APCH1-Serum Creatinine | APCH109 | 11 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 0.6-1.4 | mg/dL |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02Bored OftenGDS02044 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | NO | 0 | 12 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 46-49.9 | % |
| 1 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Good Spirits Most of Time | GDS0205 | 5 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | YES | 0 | APCH1-White Blood Count | APCH111 | 13 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 3-14.9 | 10^9/L |
| 0 |
|
| USA | North America | 1 | DR. JOHN SMITH101101GDS02-Afraid of Something Bad Happening | GDS0206 | 6 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | YES | 1 | DR. JOHN SMITH | APCH1-15 Minus Glasgow Coma Score | APCH112 | 14 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 0 |
|
| 0 |
|
| USA | North America | 1 | 55 | STUDYX | X- | 101101GDS02-Feel Happy Most of Time | GDS0207 | 7 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | NO | 1 | DR. JOHN SMITH | APCH1-A: Total Acute Physiology Score | APCH113 | 15 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 2 |
|
| 2 |
|
| USA | North America | 1 | 56 | STUDYX | X- | 10152101 | GDS02-Often Feel Helpless | GDS0208 | 8 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | YES | 1 | + SOC | APCH1-A: Total Acute Physiology Score - Analysis | APCH1TPS | 16 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 |
|
|
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH10110153GDS02-Prefer to Stay Home | GDS0209 | 9 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | NO | 0 | APCH1-B: Age Points | APCH114 | 17 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 45-54 | YEARS |
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH10110154GDS02-Memory Problems | GDS0210 | 10 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | NO | 0 | APCH1-C: Chronic Health Points | APCH115 | 18 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | for elective postoperative patients |
|
| 2 |
|
| USA | North America | 1 | DR. JOHN SMITH10110155GDS02-Wonderful to Be Alive | GDS0211 | 11 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | NO | 1 | DR. JOHN SMITH | APCH1-Total APACHE II Score | APCH116 | 19 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 | 6 |
|
| 6 |
|
| USA | North America | 1 | 60 | STUDYX | X- | 10156101 | GDS02-Feel Worthless | GDS0212 | 12 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | YES | 1 | DR. JOHN SMITH | + SOC | APCH1-Total APACHE II Score - Analysis | APCH1TS | 20 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 2020-07-13 | 13JUL2020 | 15 |
|
|
| 6 |
|
| USA | North America | 1 | 61 | STUDYX | X- | 101P00011015761DRUG A | GDS02-Feel Full of Energy | GDS0213 | 13 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | YES | 0 | DR. JOHN SMITH | SOC | APCH1-Temperature - Rectal | APCH101 | 1 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 38.5-38.9 | C |
| 1 |
|
| GBR | Non-North America | 0 | 62 | STUDYX | X- | 101P00011015862DRUG AGDS02-Feel Hopeless | GDS0214 | 14 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | YES | 1 | APCH1-Mean Arterial Pressure | APCH102 | 2 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 110-129 | mmHg |
| 2 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P00011015963DRUG AGDS02-Most People Better Off Than You | GDS0215 | 15 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | NO | 0 | APCH1-Heart Rate | APCH103 | 3 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 70-109 | beats/min |
| 0 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P000110164DRUG AGDS02- Total Score - Analysis | GDS02TS | 16 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 2013-01-12 | 12JAN2013 | 58 | 7 | Possible Depression | 10 | -3 | AVERAGE | Y | DR. JOHN SMITH | APCH1-Respiratory Rate | APCH104 | 4 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | >=50 | breaths/min |
| 4 |
|
| GBR | Non-North America | 0 | 65 | STUDYX | X- | 101P00011016065DRUG A | GDS02-Satisfied With Life | GDS0201 | 1 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | YES | 0 | DR. JOHN SMITH | SOC | APCH1-Oxygenation: A-aDO2 | APCH105A | 5 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 |
|
| Y |
|
|
| GBR | Non-North America | 0 | 66 | STUDYX | X- | 101P00011016166DRUG AGDS02-Dropped Activities and Interests | GDS0202 | 2 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | APCH1-Oxygenation: PaO2 | APCH105B | 6 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 61-70 | mmHg |
| 1 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P00011016267DRUG AGDS02-Life Is Empty | GDS0203 | 3 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | APCH1-Arterial pH | APCH106A | 7 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | <7.15 |
|
| 4 |
|
| GBR | Non-North America | 0 | 68 | STUDYX | X- | 101P00011016368DRUG AGDS02Bored OftenGDS02044 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | 8 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 |
|
| Y |
|
|
| GBR | Non-North America | 0 | 69 | STUDYX | X- | 101P00011016469DRUG AGDS02-Good Spirits Most of Time | GDS0205 | 5 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | YES | 0 | APCH1-Serum Sodium | APCH107 | 9 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 150-154 | mmol/L |
| 1 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P00011016570DRUG AGDS02-Afraid of Something Bad Happening | GDS0206 | 6 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | YES | 1 | APCH1-Serum Potassium | APCH108 | 10 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 3.5-5.4 | mmol/L |
| 0 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P00011016671DRUG AGDS02-Feel Happy Most of Time | GDS0207 | 7 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 1 | APCH1-Serum Creatinine | APCH109 | 11 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | <0.6 | mg/dL |
| 2 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P00011016772DRUG A | GDS02-Often Feel Helpless | GDS0208 | 8 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | | SOC | APCH1-Hematocrit | APCH110 | 12 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 20-29.9 | % |
| 2 |
|
| GBR | Non-North America | 0 | 73 | STUDYX | X- | 101P00011016873DRUG AGDS02-Prefer to Stay Home | GDS0209 | 9 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | APCH1-White Blood Count | APCH111 | 13 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | >=40 | 10^9/L |
| 4 |
|
| GBR | Non-North America | 0 | 74 | STUDYX | X- | 101P00011016974DRUG AGDS02-Memory Problems | GDS0210 | 10 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | APCH1-15 Minus Glasgow Coma Score | APCH112 | 14 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 3 |
|
| 3 |
|
| GBR | Non-North America | 0 | 75 | STUDYX | X- | 101P00011017075DRUG AGDS02-Wonderful to Be Alive | GDS0211 | 11 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 1 | APCH1-A: Total Acute Physiology Score | APCH113 | 15 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 24 |
|
| 24 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P00011017176YDRUG A | GDS02-Feel Worthless | GDS0212 | 12 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | APCH1-A: Total Acute Physiology Score - Analysis | APCH1TPS | 16 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 |
|
|
| 24 |
| Y | GBR | Non-North America | 0 | 77 | STUDYX | X- | 101P00011017277DRUG AGDS02-Feel Full of Energy | GDS0213 | 13 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | YES | 0 | APCH1-B: Age Points | APCH114 | 17 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 65-74 | YEARS |
| 5 |
|
| GBR | Non-North America | 0 | DR. JOHN SMITH101P00011017378DRUG AGDS02-Feel Hopeless | GDS0214 | 14 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | APCH1-C: Chronic Health Points | APCH115 | 18 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | for elective postoperative patients |
|
| 2 |
|
| GBR | Non-North America | 0 | 79 | STUDYX | X- | 101P00011017479DRUG AGDS02-Most People Better Off Than You | GDS0215 | 15 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | NO | 0 | DR. JOHN SMITH | APCH1-Total APACHE II Score | APCH116 | 19 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 | 31 |
|
| 31 |
|
| GBR | Non-North America | 0 | 80 | STUDYX | X- | 101P000110180DRUG AGDS02APCH1-Total APACHE II Score - Analysis | GDS02TS16 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 2013-02-13 | 13FEB2013 | 90 | 3 | Normal | 10 | -7 | Y | DR. JOHN SMITH20 | APACHE II | SCREENING | 1 | Baseline | 0 | 2020-08-04 | 04AUG2020 | -1 |
|
|
| 31 |
| Y | GBR | Non-North America | 0 | 81 | STUDYX | X- | 101P000110181DRUG AGDS02APCH1-Total APACHE II Score - Analysis | GDS02TS16 | GDS SHORT FORM | VISIT 4 | 4 | ENDPOINT | 7 | 2013-02-13 | 13FEB2013 | 90 | 3 | Normal | 10 | -7 | LOV | Y | DR. JOHN SMITH | |
|
Update the below dataset and title according to the current QRS Short_Name instrument.
20 | APACHE II |
|
| Day 15 (Day of Discharge) | 15 |
| 09AUG2020 | 5 |
|
|
| 38 | WOC |
| GBR | Non-North America | 0 |
|
|
APACHE II GDS SHORT FORM Summary Analysis Dataset
Due to the number of items on the instrument and instrument and the fact that only the total APACHE II score records are required for analysis, the separate summary dataset shown in the following example, which contains only the total APACHE II score records, may also be created. QSSEQ RSSEQ was not included in this example because it would be null for all computed total score records. QSORRES RSORRES is not shown because only derived total score records are displayed.
Dataset wrap |
---|
|
Dataset2 |
---|
Row | STUDYID | USUBJID | SITEID | ASEQ | ITTFL | TRTP | PARAM | PARAMCD | PARAMN | PARCAT1 | VISIT | VISITNUM | AVISIT | AVISITN | ADT | ADY | AVAL |
---|
AVALCAT1BASECHGDTYPEABLFLANL01FL1 | 101101GDS02APCH1-Total APACHE II Score - Analysis | GDS02TS16 | GDS SHORT FORM | VISIT 1BASELINE16NOV2012 | 1 | 10 | Possible Depression | 10 | Y | Y | 2 | STUDYX | X-101-P0001 | 101 | Y | DRUG A | GDS02- Total Score - Analysis | GDS02TS | 16 | GDS SHORT FORM | VISIT 2 | 2 | VISIT 2 | 2 | 15DEC2012 | 30 | 8 | Possible Depression | 10 | -2 | Y | 29JUN2020 | 1 | 22 |
| Y | USA | North America | 1 | 40 | 3101101GDS02APCH1-Total APACHE II Score - Analysis | GDS02TS16 | GDS SHORT FORM | UNSCHEDULED 2.01 | 2.01 | VISIT 2 | 2 | 28DEC2012 | 43 | 9 | Possible Depression | 10 | -1 | 20 | APACHE II | DAY 7 | 7 | Day 7 | 7 | 05JUL2020 | 7 | 14 |
|
| USA | North America | 1 | 60 | 4101101GDS02APCH1-Total APACHE II Score - Analysis | GDS02TS5 | 16 | GDS SHORT FORM | VISIT 3 | 3 | VISIT 3 | 3 | 12JAN2013 | 58 | 7 | Possible Depression | 10 | -3 | AVERAGE | Y | 20 | APACHE II | DAY 15 | 15 | Day 15 (Day of Discharge) | 15 | 13JUL2020 | 15 | 6 |
|
| USA | North America | 1 | 80 | 101P0001101DRUG AGDS02APCH1-Total APACHE II Score - Analysis | GDS02TS16 | GDS SHORT FORM | VISIT 4 | 4 | VISIT 4 | 4 | 13FEB2013 | 90 | 3 | Normal | 10 | -7 | Y | 20 | APACHE II | SCREENING | 1 | Baseline | 0 | 04AUG2020 | -1 | 31 |
| Y | GBR | Non-North America | 0 | 81 | 6101-P0001101 | Y | DRUG A | GDS02- Total Score - Analysis | GDS02TS | 16 | GDS SHORT FORM | ENDPOINT | 7 | 13FEB2013 | 90 | 3 | Normal | 10 | -7 | LOV | Y | |
|
7 References
200-P0002 | 200 | 21 | Y | SOC | APCH1-Total APACHE II Score - Analysis | APCH1TS | 20 | APACHE II |
|
| Day 15 (Day of Discharge) | 15 | 09AUG2020 | 5 | 38 | WOC |
| GBR | Non-North America | |
|
|
7 References
- Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13(10):818–29.
- Yesavage J. Geriatric depression scale. Stanford/VA/NIA Aging Clinical Research Center (ACRC) Website. Accessed May 6, 2020. http://web.stanford.edu/~yesavage/GDS.html
Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1-2):165-173. doi:10.1300/J018v05n01_09
- Burke WJ, Roccaforte WH, Wengel SP. The short form of the geriatric depression scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4(3):173-178. doi:10.1177/089198879100400310
End of Document